Lupa

Search the repository Help

A- | A+ | Print
Query: search in
search in
search in
search in
* old and bolonia study programme

Options:
  Reset


1 - 2 / 2
First pagePrevious page1Next pageLast page
1.
In vitro targeted gene electrotransfer to endothelial cells with plasmid DNA containing human endothelin-1 promoter
Nataša Tešić, Maja Čemažar, 2013, original scientific article

Found in: ključnih besedah
Summary of found: ...electroporation, endothelial cells, gene electrotransfer, human endothelin-1 promoter,...
Keywords: electroporation, endothelial cells, gene electrotransfer, human endothelin-1 promoter, osmolarity of electroporation buffer, transfection efficacy
Published: 15.10.2013; Views: 1670; Downloads: 60
URL Full text (0,00 KB)

2.
Endoglin (CD105) silencing mediated by shRNA under the control of Endothelin-1 promoter for targeted gene therapy of Melanoma
Simona Kranjc, Boris Turk, Nataša Tešić, Maja Čemažar, Véronique Préat, Gregor Serša, Urška Kamenšek, Monika Štimac, Urša Lampreht Tratar, Gaëlle Vandermeulen, Miha Butinar, 2015, original scientific article

Abstract: Endoglin (CD105), a transforming growth factor (TGF)-% coreceptor, and endothelin-1, a vasoconstrictor peptide, are both overexpressed in tumor endothelial and melanoma cells. Their targeting is therefore a promising therapeutic approach for melanoma tumors. The aim of our study was to construct a eukaryotic expression plasmid encoding the shRNA molecules against CD105 under the control of endothelin-1 promoter and to evaluate its therapeutic potential both in vitro in murine B16F10-luc melanoma and SVEC4-10 endothelial cells and in vivo in mice bearing highly metastatic B16F10-luc tumors. Plasmid encoding shRNA against CD105 under the control of the constitutive U6 promoter was used as a control. We demonstrated the antiproliferative and antiangiogenic effects of both plasmids in SVEC4-10 cells, as well as a moderate antitumor and pronounced antimetastatic effect in B16F10-luc tumors in vivo. Our results provide evidence that targeting melanoma with shRNA molecules against CD105 under the control of endothelin-1 promoter is a feasible and effective treatment, especially for the reduction of metastatic spread.
Found in: ključnih besedah
Summary of found: ...melanoma, electroporation, endoglin (CD105), endothelin-1, gene therapy, ...
Keywords: melanoma, electroporation, endoglin (CD105), endothelin-1, gene therapy
Published: 14.10.2015; Views: 1748; Downloads: 81
URL Full text (0,00 KB)

Search done in 0 sec.
Back to top
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica